Please complete the CAPTCHA to continue
@illuminaventures.com
✓
2 phones found area 858
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Wouter Meuleman is listed as Partner at Illumina Ventures, based in San Francisco Bay Area, United States, United States. AeroLeads shows a work email signal at illuminaventures.com, phone signal with area code 858, and a matched LinkedIn profile for Wouter Meuleman.
Wouter Meuleman previously worked as Principal at Illumina Ventures and Board Observer at Precede Biosciences. Wouter Meuleman holds Master Of Business Administration (Mba) from University Of Cambridge.
This section adds company-level context without repeating Wouter Meuleman's masked contact details.
AeroLeads found 1 current-domain work email signal for Wouter Meuleman. Compare company email patterns before reaching out.
Scientist | Venture Capitalist | Skateboarder
Listed skills include Start Ups, Materials Science, Life Sciences, Venture Capital, and 1 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Illumina Ventures pursues investments in early stage companies that are pioneering new applications of nucleic acid sequencing, developing products that will expand the genomics ecosystem, and utilizing genomics to improve human health.
Boston, MA, US
Precede Biosciences is breaking down the barriers to precision medicine by redefining what can be learned from a simple blood draw. By understanding the fundamental biology behind disease at any given moment, researchers and clinicians can better target medicines to the right patients in both drug development and clinical practice. Precede seeks to improve.
Boxborough, MA, US
RedShiftBio has developed a proprietary life sciences platform combining its Microfluidic Modulation Spectroscopy (MMS) and expertise in high powered quantum cascade lasers that provides ultra-sensitive and ultra-precise measurements of molecular structure.
Cambridge, England, GB
Lightcast Discovery is developing a flexible, accessible platform to accelerate single-cell, functional analysis at scale. Consolidating multiple, complex assays into intuitive streamlined workflows, the company is addressing key limitations in existing methods to provide the freedom to innovate and discover across a broad range of disciplines, from basic.
Watertown, Massachusetts, US
Fluent BioSciences, develops high sensitivity molecular analytical products that enables usage of extremely low molecular and cellular sample inputs.
Durham, North Carolina, US
Ribometrix is a platform therapeutics company discovering small-molecule drugs that target functional RNA structures to create new avenues to treat human disease.
Houston, TX, US
Biota applies DNA sequencing and data science to explore the earth's subsurface. It offers DNA data services for production profiling, sweet spot identification, and reservoir connectivity.
Le Kremlin-Bicêtre, Île-de-France, FR
DNA Script is focused on the manufacturing of synthetic DNA using a proprietary template-free enzymatic technology. This technology has the potential to greatly accelerate the development of new therapeutics, sustainable chemical production, improved crops as well as new applications such as data storage.
San Diego, CA, US
Illumina, Inc. is a Life Sciences tools company developing, manufacturing and marketing integrated systems for the analysis of genetic variation and biological function.
Cambridge, Massachusetts, US
Desktop Genetics aims to help researchers discover and treat the root genetic causes of human disease. The company offers sgRNA design tools, custom CRISPR library design, and analysis services to investigators globally. Desktop Genetics was acquired by Celixir in May, 2018.
Kidlington, Oxfordshire, GB
Founded by Professor Ed Southern, Oxford Gene Technology (OGT) provides innovative genetics research solutions to advance molecular medicine.
Oxamer was founded in the autumn of 2002 by Professor Edwin M. Southern, Ryan D. Egeland, and John Jarvis to commercialise an electrochemical method for DNA microarray fabrication.
Newcastle Upon Tyne, Tyne And Wear, GB
Research on methanol reformate fuel cells; synthesis and characterization of methanol resistant electrocatalysts; recovery of precious metals from catalyst waste.
Quick answers generated from the profile data available on this page.
Wouter Meuleman works for Illumina Ventures.
Wouter Meuleman is listed as Partner at Illumina Ventures.
AeroLeads has found 1 work email signal at @illuminaventures.com for Wouter Meuleman at Illumina Ventures.
AeroLeads has found 2 phone signal(s) with area code 858 for Wouter Meuleman at Illumina Ventures.
Wouter Meuleman is based in San Francisco Bay Area, United States, United States while working with Illumina Ventures.
Wouter Meuleman has worked for Illumina Ventures, Precede Biosciences, Redshiftbio, Lightcast Discovery, and Fluent Biosciences Inc..
You can use AeroLeads to view verified contact signals for Wouter Meuleman at Illumina Ventures, including work email, phone, and LinkedIn data when available.
Wouter Meuleman holds Master Of Business Administration (Mba) from University Of Cambridge.
Wouter Meuleman is listed with skills including Start Ups, Materials Science, Life Sciences, Venture Capital, and Genomics.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts